{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:41:38Z","timestamp":1792287698551,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.celrep.2026.117289","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:29:12Z","timestamp":1776893352000},"page":"117289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive mass spectrometry screening-derived atlas of HDAC inhibitors reveals histone-specific acetylation changes"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-517X","authenticated-orcid":false,"given":"Rashmi","family":"Karki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca N. De Luna","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Searfoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Lempi\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl H.","family":"Arrowsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117289_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","article-title":"The language of chromatin modification in human cancers","volume":"21","author":"Zhao","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.117289_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8 \u00c5 resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117289_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117289_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.10.011","article-title":"Epigenetics and cancer treatment","volume":"625","author":"Kristensen","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.celrep.2026.117289_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2012.06.014","article-title":"Development and therapeutic impact of HDAC6-selective inhibitors","volume":"84","author":"Dallavalle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.celrep.2026.117289_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.117289_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.celrep.2026.117289_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1387\/ijdb.082649rb","article-title":"Histone deacetylase 1 and 2-controlled embryonic development and cell differentiation","volume":"53","author":"Brunmeir","year":"2009","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.celrep.2026.117289_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117289_bib10","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41588-019-0514-8","article-title":"HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype","volume":"51","author":"Malhotra","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117289_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97903","article-title":"PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy","volume":"4","author":"Nishimori","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2026.117289_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/13543784.2010.510514","article-title":"The clinical development of histone deacetylase inhibitors as targeted anticancer drugs","volume":"19","author":"Marks","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.celrep.2026.117289_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/dom.12470","article-title":"Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats","volume":"17","author":"Lundh","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.celrep.2026.117289_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"Mihaylova","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117289_bib15","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa041892","article-title":"Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease","volume":"352","author":"Ito","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117289_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: What makes it different from the other HDACs?","volume":"8","author":"Sim\u00f5es-Pires","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2026.117289_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107057","article-title":"Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma","volume":"208","author":"El Omari","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.celrep.2026.117289_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"Somoza","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2026.117289_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tem.2012.09.003","article-title":"Metabolic reprogramming by class I and II histone deacetylases","volume":"24","author":"Mihaylova","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2026.117289_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcdb.2022.03.011","article-title":"Histone H2A variants: Diversifying chromatin to ensure genome integrity","volume":"135","author":"Oberdoerffer","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.celrep.2026.117289_bib21","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1038\/sj.onc.1205431","article-title":"Erratum: Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization","volume":"21","author":"Dunican","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2026.117289_bib22","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1073\/pnas.0401994101","article-title":"Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression","volume":"101","author":"Rhodes","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117289_bib23","doi-asserted-by":"crossref","first-page":"18147","DOI":"10.1073\/pnas.0408260101","article-title":"Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis","volume":"101","author":"Zucchi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117289_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1471-2407-13-215","article-title":"Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression","volume":"13","author":"M\u00fcller","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.celrep.2026.117289_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","article-title":"High-Resolution Profiling of Histone Methylations in the Human Genome","volume":"129","author":"Barski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117289_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2008.02.022","article-title":"Dynamic Regulation of Nucleosome Positioning in the Human Genome","volume":"132","author":"Schones","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117289_bib27","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.2174\/092986710792231941","article-title":"Histone Variant H2A.Z Can Serve as a New Target for Breast Cancer Therapy","volume":"17","author":"Rangasamy","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.celrep.2026.117289_bib28","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1101\/gad.1545707","article-title":"p21 transcription is regulated by differential localization of histone H2A","volume":"21","author":"G\u00e9vry","year":"2007","journal-title":"Z. Genes Dev."},{"key":"10.1016\/j.celrep.2026.117289_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gr.118919.110","article-title":"Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer","volume":"22","author":"Vald\u00e9s-Mora","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.celrep.2026.117289_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4161\/epi.5.4.11520","article-title":"Reconciling the positive and negative roles of histone H2A.Z in gene transcription","volume":"5","author":"Marques","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.celrep.2026.117289_bib31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S1097-2765(01)00269-6","article-title":"Histone H2A.Z acetylation modulates an essential charge patch","volume":"7","author":"Ren","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117289_bib32","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1093\/nar\/gki874","article-title":"The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken","volume":"33","author":"Bruce","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117289_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1101\/gad.1395506","article-title":"Acetylation of H2AZ Lys 14 is associated with genome-wide gene activity in yeast","volume":"20","author":"Millar","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2026.117289_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13072-019-0274-9","article-title":"The histone variant H2A.Z in gene regulation","volume":"12","author":"Giaimo","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.celrep.2026.117289_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1741-7007-7-86","article-title":"Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates","volume":"7","author":"Dryhurst","year":"2009","journal-title":"BMC Biol."},{"key":"10.1016\/j.celrep.2026.117289_bib36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1101\/gad.1787109","article-title":"Histone H2A.Z is essential for estrogen receptor signaling","volume":"23","author":"G\u00e9vry","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2026.117289_bib37","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1074\/mcp.M114.046011","article-title":"Epiprofile quantifies histone peptides with modifications by extracting retention time and intensity in high-resolution mass spectra","volume":"14","author":"Yuan","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"111","key":"10.1016\/j.celrep.2026.117289_bib38","doi-asserted-by":"crossref","DOI":"10.3791\/54112","article-title":"Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: From histone extraction to data analysis","author":"Sidoli","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.celrep.2026.117289_bib39","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/jasms.3c00223","article-title":"An Optimized and High-Throughput Method for Histone Propionylation and Data-Independent Acquisition Analysis for the Identification and Quantification of Histone Post-translational Modifications","volume":"34","author":"Searfoss","year":"2023","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.celrep.2026.117289_bib40","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C003307C","article-title":"Quantitative proteomics reveals direct and indirect alterations in the histone code following methyltransferase knockdown","volume":"6","author":"Plazas-Mayorca","year":"2010","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.celrep.2026.117289_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1188\/12.CJON.195-204","article-title":"Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma","volume":"16","author":"Frye","year":"2012","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.celrep.2026.117289_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): A natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"Vandermolen","year":"2011","journal-title":"J. Antibiot."},{"key":"10.1016\/j.celrep.2026.117289_bib43","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ctrv.2014.08.001","article-title":"Therapeutic options in relapsed or refractory peripheral T-cell lymphoma","volume":"40","author":"Coiffier","year":"2014","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.celrep.2026.117289_bib44","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1021\/acs.jproteome.5b00245","article-title":"Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry","volume":"14","author":"Krautkramer","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.celrep.2026.117289_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117469","article-title":"Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6\/STAT3 signalling pathways","volume":"248","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.celrep.2026.117289_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/13543784.2017.1353077","article-title":"Entinostat for the treatment of breast cancer","volume":"26","author":"Trapani","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.celrep.2026.117289_bib47","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.exphem.2011.07.002","article-title":"The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors","volume":"39","author":"J\u00f3na","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.celrep.2026.117289_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdermsci.2015.10.016","article-title":"Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptor\u03b22, via histone acetylation","volume":"81","author":"Kato","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.celrep.2026.117289_bib49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2217\/fon-2016-0526","article-title":"Entinostat: A promising treatment option for patients with advanced breast cancer","volume":"13","author":"Connolly","year":"2017","journal-title":"Future Oncol."},{"key":"10.1016\/j.celrep.2026.117289_bib50","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s43018-024-00729-w","article-title":"Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial","volume":"5","author":"Roussos Torres","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117289_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv152","article-title":"Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma","volume":"107","author":"Georgy","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.celrep.2026.117289_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1158\/1541-7786.MCR-13-0247","article-title":"Epigenetic inactivation and tumor-suppressor behavior of NGFR in human colorectal cancer","volume":"13","author":"Yang","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117289_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117289_bib54","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117289_bib55","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1158\/1078-0432.CCR-17-1043","article-title":"Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases","volume":"23","author":"Kotian","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117289_bib56","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/gb-2012-13-10-r85","article-title":"H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions","volume":"13","author":"Ku","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2026.117289_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117289_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117289_bib59","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","article-title":"RSeQC: Quality control of RNA-seq experiments","volume":"28","author":"Wang","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117289_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117289_bib61","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117289_bib62","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1101\/gr.136184.111","article-title":"ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia","volume":"22","author":"Landt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.celrep.2026.117289_bib63","unstructured":"Stark, R., and Brown, G. (2011). DiffBind : differential binding analysis of ChIP-Seq peak data. R package version 100. , 2-21. http:\/\/bioconductor.org\/packages\/release\/bioc\/html\/DiffBind.html"},{"key":"10.1016\/j.celrep.2026.117289_bib64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117289_bib65","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/nar\/gkv412","article-title":"Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses","volume":"43","author":"Liu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117289_bib66","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/nar\/gkt1033","article-title":"SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor","volume":"42","author":"Paakinaho","year":"2014","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726003670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726003670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:31:12Z","timestamp":1782505872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726003670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211124726003670"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117289","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive mass spectrometry screening-derived atlas of HDAC inhibitors reveals histone-specific acetylation changes","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117289"}}